Clinical Trial Detail

NCT ID NCT01061788
Title A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Duke University
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

Everolimus + Ganitumab + Panitumumab

Age Groups: adult

No variant requirements are available.